Allan C Silber Point Biopharma Global Inc. (PNT) insider trading activity

PNT Quotes by TradingView

Allan C Silber is Executive Chairman of POINT Biopharma Global Inc.. Currently has a direct ownership of 4.27 Million shares of PNT, which is worth approximately $0. The most recent transaction as insider was on Nov 18, 2022, when has been sold 22,397 shares (Common Stock) at a price of $6.5 per share, resulting in proceeds of $145,580. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.27M
0% 3M change
0% 12M change
Total Value Held $0

ALLAN C SILBER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2022
BUY
Open market or private purchase
$145,580 $6.5 p/Share
22,397 Added 0.52%
4,268,605 Common Stock
Nov 17 2022
BUY
Open market or private purchase
$165,618 $6.0 p/Share
27,603 Added 0.65%
4,246,208 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
4,218,605 Added 50.0%
4,218,605 Common Stock

Also insider at

HGBL
Heritage Global Inc. Financial Services
> 10% Shareholder
ACS

Allan C Silber

Executive Chairman
Toronto, A6

Track Institutional and Insider Activities on PNT

Follow POINT Biopharma Global Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PNT shares.

Notify only if

Insider Trading

Get notified when an Point Biopharma Global Inc. insider buys or sells PNT shares.

Notify only if

News

Receive news related to POINT Biopharma Global Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PNT